Moomoo AI 已提取核心訊息
Novavax, Inc. has announced a significant workforce reduction as part of its global restructuring and cost reduction plan. On January 30, 2024, the company's Board of Directors approved a 12% reduction in its global workforce, which includes a 9% cut in full-time employees and the remainder affecting contractors and consultants. The company anticipates that the full annual impact of the cost savings will be realized in 2025, with approximately 85% of the savings expected in 2024, excluding one-time charges. Novavax is expected to incur one-time charges of $4 million to $7 million for employee severance and benefit costs, primarily within the first quarter of 2024. This reduction will result in a workforce that is about 30% smaller than it was at the end of the first quarter of 2023. The company has made forward-looking statements regarding the expected timing and impact of the cost savings from the restructuring plan, but also cautions that these statements involve risks and uncertainties that could cause actual results to differ materially from expectations.
Novavax, Inc. has announced a significant workforce reduction as part of its global restructuring and cost reduction plan. On January 30, 2024, the company's Board of Directors approved a 12% reduction in its global workforce, which includes a 9% cut in full-time employees and the remainder affecting contractors and consultants. The company anticipates that the full annual impact of the cost savings will be realized in 2025, with approximately 85% of the savings expected in 2024, excluding one-time charges. Novavax is expected to incur one-time charges of $4 million to $7 million for employee severance and benefit costs, primarily within the first quarter of 2024. This reduction will result in a workforce that is about 30% smaller than it was at the end of the first quarter of 2023. The company has made forward-looking statements regarding the expected timing and impact of the cost savings from the restructuring plan, but also cautions that these statements involve risks and uncertainties that could cause actual results to differ materially from expectations.
Novavax, Inc. 宣佈大幅裁員，這是其全球重組和成本削減計劃的一部分。2024 年 1 月 30 日，公司董事會批准裁員 12% 的全球員工，其中包括裁員 9% 的全職員工，其餘部分影響承包商和顧問。該公司預計，成本節省的全部年度影響將在2025年實現，其中約85％的節省預計將在2024年實現，其中不包括一次性費用。預計Novavax將主要在2024年第一季度內一次性支付400萬至700萬美元的員工遣散費和福利費用。這種裁員將導致員工人數比2023年第一季度末減少約30％。該公司已就重組計劃節省成本的預期時機和影響做出了前瞻性陳述，但也警告說，這些陳述涉及風險和不確定性，可能導致實際業績與預期存在重大差異。
Novavax, Inc. 宣佈大幅裁員，這是其全球重組和成本削減計劃的一部分。2024 年 1 月 30 日，公司董事會批准裁員 12% 的全球員工，其中包括裁員 9% 的全職員工，其餘部分影響承包商和顧問。該公司預計，成本節省的全部年度影響將在2025年實現，其中約85％的節省預計將在2024年實現，其中不包括一次性費用。預計Novavax將主要在2024年第一季度內一次性支付400萬至700萬美元的員工遣散費和福利費用。這種裁員將導致員工人數比2023年第一季度末減少約30％。該公司已就重組計劃節省成本的預期時機和影響做出了前瞻性陳述，但也警告說，這些陳述涉及風險和不確定性，可能導致實際業績與預期存在重大差異。
有用
沒用